Skip to content
Prof. Dr. Mustafa Özdoğan · Medical Oncologist

Has Russia found a coronavirus treatment? What is mefloquine, does it help with COVID-19, and what are its side effects?

Has Russia found a coronavirus treatment? What is mefloquine, does it help with COVID-19, and what are its side effects?

Mefloquine is an old, well-known malaria drug developed in the 1970s and actively used after the 1980s, yet headlines say it was "discovered by Russia". Might Putin have become annoyed and said, "What is this? Nobody is mentioning us. Put out a bombshell story through our Sputnik News"?

The old history of the new (?) treatment!..

Mefloquine is a compound developed in 1970 as a synthetic analogue of quinine. Quinine was the first drug used to treat malaria and was isolated in the 1820s from the cinchona plant.

Mefloquine has a very long half-life (20 days) because of its enterohepatic (gut-liver) circulation and accumulation in various tissues. Neuropsychiatric side effects mean that it is not a first-choice drug for treating malaria. Mefloquine may be preferred when there is resistance to other drugs. It is not suitable for people with epilepsy (seizures).

Does mefloquine have a role in treating COVID-19?

First, it should be noted that COVID-19, the illness caused by the novel coronavirus currently has no specific treatment. However, numerous new and existing drugs and methods are being tested for COVID-19. Indeed, treating coronavirus and developing a preventive vaccine are currently, without question, the world's highest priorities. Mefloquine, however, is certainly not among the first drugs that come to mind when discussing coronavirus treatment trials!

A statement released today by Russia's Federal Biomedical Agency claimed that a "mefloquine-based" drug had been developed against COVID-19. The statement claimed that the drug would "enable the epidemic's peak to be overcome and keep it under control in the future".

First, let us present a summary of drugs being tested to treat coronavirus disease, then discuss a review on mefloquine published by Chinese scientists that, interestingly, did not originate in Russia:

Why are scientific studies conducted to repurpose an old drug used in another field?

Developing a drug from scratch is a very demanding process in many respects. Knowing an authorized drug's pharmacokinetic properties in animal models, having tested it in clinical trials, and, most importantly, knowing that it is safe in humans offer many advantages. It also provides a shortcut in terms of chemical synthesis and manufacturing processes. Generating added value from existing drugs is a strategic, time-saving and less costly solution than developing a drug from scratch. It is considered a rational approach to tackling a rapidly spreading global outbreak.

The table above shows drugs evaluated for the novel coronavirus in studies at various levels. However, similar long lists exist for other viruses that cause disease in humans. A comprehensive review published in the International Journal of Infectious Diseases evaluated the use of 120 antiviral drugs as broad-spectrum agents and the quality of the research on them. A 'broad-spectrum antiviral agent' is a drug targeting multiple viruses or virus families, rather than a single virus or family. Broad-spectrum antivirals have been considered because different viruses use similar pathways to enter host cells and exert their effects. Drugs such as mefloquine were not initially developed for antiviral treatment but were subsequently investigated for antiviral activity. Mefloquine, for example, is being studied for a different use despite originally being an antiparasitic drug for malaria, as noted above. The list includes many drugs besides mefloquine. These are authorized for various purposes, including bacterial infections (antibacterial/antibiotic drugs), cancer treatment, immunosuppressive treatment, psychosis and cardiac arrhythmias. In addition to these uses, studies have examined their use in various viral diseases.

A search of the scientific literature reveals very few studies investigating mefloquine for COVID-19 associated with the novel coronavirus (SARS-CoV-2). This scarcity is particularly striking given the thousands of scientific publications on the novel coronavirus in recent months. Chinese Medical Journal published a study on March 6, 2020, in which numerous commercially available drugs were tested on in vitro cell cultures from pangolins (in vitro cell culture means growing the cells in a suitable laboratory setting). The agents cepharanthine, selamectin and mefloquine were reported to be effective against coronavirus in pangolin cells in the laboratory. Cepharanthine appeared to be the most effective of these agents and was suggested as a candidate for testing in humans.

In conclusion, there are no data amounting to scientific evidence that mefloquine is effective in treating the novel coronavirus "in humans". Only a very small number of in vitro cell culture studies exist; even animal studies, the next step, are absent.

Why, then, did Russia announce this through the press without any scientific data to show, rather than scientifically publishing the treatment it claims to have found?

Is Russia's response to coronavirus an example for everyone, or propaganda driven by electoral and commercial concerns?

Are Russia's reported low case and mortality rates real, or are the numbers being hidden? So far, a total of 1264 cases and 228 deaths have been reported. However, many Russians on social media say that the authorities are not being transparent, recalling the country's history of the Chernobyl disaster. Many cases are reportedly recorded as deaths from pneumonia unrelated to COVID-19. There are also numerous reports of arrests of Russian opposition citizens who voice such views. There is a Russian presidential election dimension as well. Had the coronavirus pandemic not occurred, an election likely to give Putin lifetime presidential powers would have taken place. However, the election was canceled as the outbreak spread nationwide. A nationwide holiday was declared for next week. 

- ALL OUR CORONAVIRUS ARTICLES -

Sources

1. Fan, Hua-Hao; Wang, Li-Qin; Liu, Wen-Li; An, Xiao-Ping; Liu, Zhen-Dong; He, Xiao-Qi; Song, Li-Hua; Tong, Yi-GangSection Editor(s): Wei, Pei-Fang.
Repurposing of clinically approved drugs for treatment of coronavirus disease 2019 in a 2019-novel coronavirus (2019-nCoV) related coronavirus model.
Chinese Medical Journal: March 06, 2020

2. Andrew Roth in Moscow
Coronavirus delays Russian vote on Putin staying in power.
theguardian.com - Published onWed 25 Mar 2020

Appointment request

DROZDOGAN AI

Explore this article together

Ask about the article and read answers alongside published sources from our site.

DROZDOGAN AI

Drozdogan Assistant

Has Russia found a coronavirus treatment? What is mefloquine, does it help with COVID-19, and what are its side effects?

Ask about the article and read answers alongside published sources from our site.

Conversation and privacy information

Drozdogan Assistant answers this conversation. Authorized site administrators may review it for quality. Do not share personal information.

Replies use OpenAI infrastructure. Questions and replies are processed by that service; conversation records are stored on our site. Do not share identifying, contact or personal health information.

0 / 1000

For information only; no personal diagnosis or treatment advice.

Related articles

Explore other articles on this topic.

Stay informed

Receive new articles and scientific updates by email.

Google Analytics runs on public pages independently of this window and may use analytics cookies. Your choice here controls external services only.

Cookie policy